ORTHOBIOLOGICS REIMAGINED
DEAD

Serial Number

88597767

Owner

Regenacell Therapy, Inc.

Attorney

Arvid von Taube

Filing Date

Aug 29, 2019

Add to watchlist:

No watchlists yet
View on USPTO

ORTHOBIOLOGICS REIMAGINED Trademark

Serial Number: 88597767

ORTHOBIOLOGICS REIMAGINED is a trademark filed by Regenacell Therapy, Inc. on August 29, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

Regenacell Therapy, Inc. (4 trademarks)

2328 Saddleback Drive
Castle Rock, CO 80104

Entity Type: 03

Trademark Details

Filing Date

August 29, 2019

Registration Date

Not Registered

Published for Opposition

July 7, 2020

Goods & Services

Organic biological bone graft materials

Medical devices and materials, namely, devices to aspirate bone marrow and harvest autologous bone dowels, synthetic and organic bone graft substitute materials and devices to aspirate bone marrow in the extremities and harvest bone graft; Medical apparatus for the delivery of the combination of bone marrow, autologous bone dowels and bone graft material to the surgical site; Medical device pack consisting of a combination of medical devices and materials, namely, devices to aspirate bone marrow and harvest autologous bone dowels and synthetic and organic bone graft substitute materials with medical apparatus for the delivery of the combination of bone marrow, autologous bone dowels and bone graft material to the surgical site; Medical device pack consisting of a combination of medical devices and materials, namely, devices to aspirate bone marrow in the extremities and harvest bone graft and synthetic bone graft substitute materials; Marrow aspiration devices with and without the device to harvest autologous bone dowels; Medical and surgical devices and instruments, namely, adipose tissue harvesting and centrifuge disposable apparatus for creating a high density 3D adipose scaffold and the ability to process infranatant for High Density Cellular Fraction; Disposable medical device that processes peripheral blood in a centrifuge

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 2, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 2, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 22, 2023 EXRA
SOU EXTENSION 5 GRANTED
Feb 21, 2023 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 21, 2023 AITU
SOU EXTENSION 5 FILED
Feb 2, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Feb 2, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 20, 2022 EXRA
SOU EXTENSION 4 GRANTED
Aug 18, 2022 EX4G
SOU EXTENSION 4 FILED
Aug 18, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Aug 18, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 10, 2022 EXRA
SOU EXTENSION 3 GRANTED
Feb 8, 2022 EX3G
SOU EXTENSION 3 FILED
Feb 8, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 8, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 18, 2021 EXRA
SOU EXTENSION 2 GRANTED
Aug 16, 2021 EX2G
SOU EXTENSION 2 FILED
Aug 16, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 16, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 2, 2021 EXRA
SOU EXTENSION 1 GRANTED
Feb 26, 2021 EX1G
SOU EXTENSION 1 FILED
Feb 26, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 26, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 1, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 7, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jul 7, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 17, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 4, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 3, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 2, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 2, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 3, 2019 GNRN
NON-FINAL ACTION E-MAILED
Dec 3, 2019 GNRT
NON-FINAL ACTION WRITTEN
Dec 3, 2019 CNRT
ASSIGNED TO EXAMINER
Dec 3, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 11, 2019 NWOS
NEW APPLICATION ENTERED
Sep 2, 2019 NWAP